These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8048291)

  • 41. Association of elevated serum heat-shock protein 70 concentration with transient hypertension of pregnancy, preeclampsia and superimposed preeclampsia: a case-control study.
    Molvarec A; Prohászka Z; Nagy B; Szalay J; Füst G; Karádi I; Rigó J
    J Hum Hypertens; 2006 Oct; 20(10):780-6. PubMed ID: 16761027
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Plasma fibronectin: a marker of arterial hypertension in pregnancy?].
    Azar R; Turpin D
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(7):863-6. PubMed ID: 2614025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Measurement of plasma fibronectin concentrations in normal pregnancy and pregnancy induced hypertension and its clinical significance].
    Yao ZW; Mao YL; Chen JZ
    Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):521-3, 572. PubMed ID: 7835126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Fibronectin: a predictive marker for preeclampsia].
    Grisaru D; Lessing JB; Peyser MR
    Harefuah; 1994 Jul; 127(1-2):22-4. PubMed ID: 7959382
    [No Abstract]   [Full Text] [Related]  

  • 45. Plasminogen activator of urokinase type and its inhibitor of placental type in hypertensive pregnancies and in intrauterine growth retardation: possible markers of placental function.
    Lindoff C; Astedt B
    Am J Obstet Gynecol; 1994 Jul; 171(1):60-4. PubMed ID: 8030735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Total fibronectin in maternal plasma as a predictor for preeclampsia.
    Gredmark T; Bergman B; Hellström L
    Gynecol Obstet Invest; 1999; 47(2):89-94. PubMed ID: 9949277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New placental proteins in placental dysfunction.
    Lee JN; Chard T
    Contrib Gynecol Obstet; 1982; 9():157-69. PubMed ID: 6183052
    [No Abstract]   [Full Text] [Related]  

  • 48. Platelets and intrauterine growth retardation in pre-eclampsia.
    Trudinger BJ
    Br J Obstet Gynaecol; 1976 Apr; 83(4):284-6. PubMed ID: 1268136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma cellular fibronectin as a measure of endothelial involvement in preeclampsia and intrauterine growth retardation.
    Friedman SA; de Groot CJ; Taylor RN; Golditch BD; Roberts JM
    Am J Obstet Gynecol; 1994 Mar; 170(3):838-41. PubMed ID: 8141213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma fibronectin levels and age-corrected birth weight in hypertensive-normotensive mothers and their newborns.
    Orbak Z; Zor N; Akçay F; Kaya D
    J Trop Pediatr; 1998 Feb; 44(1):49-51. PubMed ID: 9538608
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Kallikrein (urine) in pregnancy-induced hypertension].
    Schröcksnadel H; Alge A; Sitte BA; Artner E; Kirchebner P; Daxenbichler G
    Geburtshilfe Frauenheilkd; 1995 Oct; 55(10):580-2. PubMed ID: 8543132
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone.
    Taylor RN; Crombleholme WR; Friedman SA; Jones LA; Casal DC; Roberts JM
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 1):895-901. PubMed ID: 1951550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fibronectin and antithrombin as markers of pre-eclampsia in pregnancy.
    Paternoster DM; Stella A; Simioni P; Girolami A; Plebani M
    Eur J Obstet Gynecol Reprod Biol; 1996 Dec; 70(1):33-9. PubMed ID: 9031918
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibronectin levels in normal pregnancy and preeclampsia.
    Chen CK; Lee CN; Shyu MK; Hwa HL; Chen CD; Sheu BC; Hsieh FJ
    J Formos Med Assoc; 1994; 93(11-12):921-4. PubMed ID: 7633195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Monitoring of HPL, estriol and estetrol in high-risk pregnancy].
    Gherzi R; Pastore M; Labate D
    Minerva Ginecol; 1981 Oct; 33(10):911-6. PubMed ID: 7312213
    [No Abstract]   [Full Text] [Related]  

  • 56. [Lipid test, a test for placental insufficiency (a preliminary report)].
    Papazov B; Karag'ozov A; Pranchev N; Karag'ozov I
    Akush Ginekol (Sofiia); 1978; 17(4):256-61. PubMed ID: 696965
    [No Abstract]   [Full Text] [Related]  

  • 57. Quantification of extracellular DNA using hypermethylated RASSF1A, SRY, and GLO sequences--evaluation of diagnostic possibilities for predicting placental insufficiency.
    Hromadnikova I; Zejskova L; Kotlabova K; Jancuskova T; Doucha J; Dlouha K; Krofta L; Jirasek JE; Vlk R
    DNA Cell Biol; 2010 Jun; 29(6):295-301. PubMed ID: 20235876
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Significance of uric acid concentration in the serum for the early recognition of the risk of EPH gestosis].
    Riedel H
    Fortschr Med; 1981 Oct; 99(37):1505-10. PubMed ID: 7297989
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation between placental bed biopsy findings, vascular cell adhesion molecule and fibronectin levels in pre-eclampsia.
    Madazli R; Budak E; Calay Z; Aksu MF
    BJOG; 2000 Apr; 107(4):514-8. PubMed ID: 10759271
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extreme elevation of placental alkaline phosphatase as a marker of preterm delivery, placental insufficiency and low birth weight.
    Ferianec V; Linhartová L
    Neuro Endocrinol Lett; 2011; 32(2):154-7. PubMed ID: 21552196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.